Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma
Phase 1
Recruiting
- Conditions
- LiposarcomaRecurrent LiposarcomaMetastatic LiposarcomaUnresectable LiposarcomaMDM2 Gene AmplificationMyxoid LiposarcomaCIC-Rearranged Sarcoma
- Interventions
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Michael Wagner
- Target Recruit Count
- 24
- Registration Number
- NCT06414434
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
News
No news found